Officials in the pharmaceutical sector in Iran have warned of a worsening drug shortage crisis, stating that the stock of hundreds of drug items in the country has fallen to below one to three months. Concurrently, the Director General of Drugs and Controlled Substances at the Food and Drug Administration announced that the country's pharmaceutical system is in the 'worst possible condition' in terms of currency and rial.
Iran's Stock of Hundreds of Drug Items Has Fallen Below Three Months
Iranian pharmaceutical officials have raised alarms about a significant drug shortage, with stocks dwindling to less than three months. The situation highlights the severe economic challenges facing the country's healthcare system, impacting public health.
👥 Key Players
📰 What Happened
Iran is facing a severe drug shortage, with stocks of hundreds of medications falling to below three months. Officials have described the pharmaceutical system as being in its worst condition due to economic challenges.
- Hundreds of drug items have less than three months of stock remaining.
- The pharmaceutical system is struggling due to currency issues and economic instability.
💡 Why It Matters
📚 Background
Iran has been facing economic difficulties due to international sanctions and mismanagement, which have severely impacted its healthcare system.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%